Calibr, a division of Scripps Research dedicated to the “bench to bedside” development of transformative medicines, and the Bill & Melinda Gates Medical Research Institute (Gates MRI), today announced...

By NewsDesk  @bactiman63 Results from an international, randomized, controlled clinical trial indicate that a four-month daily treatment regimen containing high-dose, or “optimized,” rifapentine...

By NewsDesk  @infectiousdiseasenews On Wednesday, the US Food and Drug Administration (FDA) approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific...

Johns Hopkins researchers report success with a smart phone video-based app that substitutes for a daily in-person visit by a health care worker required for tuberculosis treatment known as directly observed...

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections. Brian VanderVen, assistant professor of microbiology and immunology,...